Component
Human lipid, inflammatory and oxidation surrogate-marker panel
Species, preparation, dose and limitations are retained on linked claims.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
The same one-week trial did not detect significant changes in lipid profile or tested inflammation and oxidation markers.
Experimental context and source evidence
- dose
- 5 or 25 mg/day hydroxytyrosol
- duration
- 1 week
- evidence_access
- Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
- evidence_scope
- literature_reviewed; model-specific source-derived curation
- experimental_model
- Human randomized placebo-controlled trial
- limitations
- Short duration and surrogate outcomes limit inference, but the null result should accompany mechanistic claims.
- nutrient_topic
- Hydroxytyrosol chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Hydroxytyrosol
- organism
- Human randomized placebo-controlled trial
- plain_language
- The same one-week trial did not detect significant changes in lipid profile or tested inflammation and oxidation markers.
- primary_references
- One-week administration of hydroxytyrosol to humans does not activate Phase II enzymes. (2015). https://pubmed.ncbi.nlm.nih.gov/25836918/ DOI: 10.1016/j.phrs.2015.03.018
- route
- Oral
- tissue
- Cardiovascular surrogate markers
Hydroxytyrosol: mechanism of action and interactions (2026-09-20) · lines 77–86
Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · Human randomized placebo-controlled trial · source_derived_draft · unverified_draft
## hydroxytyrosol-cardiometabolic-null The same one-week trial did not detect significant changes in lipid profile or tested inflammation and oxidation markers. Model/species: Human randomized placebo-controlled trial Tissue/system: Cardiovascular surrogate markers Exposure: 5 or 25 mg/day hydroxytyrosol Route: Oral Duration: 1 week Limits: Short duration and surrogate outcomes limit inference, but the null result should accompany mechanistic claims. Primary reference: One-week administration of hydroxytyrosol to humans does not activate Phase II enzymes. (2015). https://pubmed.ncbi.nlm.nih.gov/25836918/ DOI: 10.1016/j.phrs.2015.03.018 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.